Quantitation of human immunodeficiency virus type 1 RNA in different biological compartments

Journal of Clinical Microbiology

Volumn 38, Issue 4, 2000, Pages 1414-1418

  Shepard, Robin N ^a   Schock, Jody ^a   Robertson, Kevin ^a   Shugars, Diane C ^a,b   Dyer, John ^a   Vernazza, Pietro ^c   Hall, Colin ^a   Cohen, Myron S ^d   Fiscus, Susan A ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c St Andrew's Ipswich Private Hospital   (Australia)

^d Inst Clin Microbiol and Immunol   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ARTICLE; BREAST MILK; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEMINAL PLASMA; TISSUE DISTRIBUTION; VAGINA DISCHARGE; VIRUS LOAD;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0034005170     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.38.4.1414-1418.2000     Document Type: Article

References (30)

1. Boom, R., C. J. A. Sol, M. M. Salimans, C. L. Jansen, P. M. E. Wertheim-van Dillen, and J. van der Noordaa. 1990. Rapid and simple method for purification of nucleic acids. J. Clin. Microbiol. 28:495-503.
2. Cinque, P., L. Vago, D. Ceresa, F. Mainini, M. R. Terrini, A. Vagani, W. Torri, S. Bossolasco, and A. Lazzarin. 1998. Cerebrospinal fluid HIV-1 RNA levels: correlation with HIV encephalitis. AIDS 12:389-394.
3. Coombs, R. W., C. E. Speck, J. P. Hughes, W. Lee, R. Sampoleo, S. O. Ross, J. Dragavon, G. Peterson, T. M. Hooten, A. C. Collier, L. Corey, L. Koutsky, and J. N. Krieger. 1998. Association between culturable human immunodeficiency virus type 1 in semen and HIV-1 RNA levels in blood: evidence for compartmentalization of HIV-1 between semen and blood. J. Infect. Dis. 177:320-330.
4. Dyer, J. R., B. L. Gilliam, J. J. Eron, L. Grosso, M. S. Cohen, and S. A. Fiscus. 1996. Quantitation of human immunodeficiency virus type 1 RNA in cell free seminal plasma: comparison of NASBA and Amplicor reverse transcription-PCR amplification and correlation with quantitative culture. J. Virol. Methods 60:161-170.
5. Dyer, J. R., C. D. Pilcher, R. Shepard, J. Schock, J. J. Eron, and S. A. Fiscus. 1999. Comparison of NucliSens and Roche Monitor assays for quantitation of levels of human immunodeficiency virus type 1 RNA in plasma. J. Clin. Microbiol. 37:447-449.
6. Eron, J. J., L. Smeaton, S. Fiscus, J. Currier, J. Lennox, R. D'Aquila, M. Rogers, R. M. Gulick, and R. L. Murphy. The effects of antiretroviral therapy with protease inhibitor-containing regimens on HIV-1 levels in semen. J. Infect. Dis., in press.
7. Farrar, D. J., S. Cu Uvin, A. M. Caliendo, S. F. Costello, D. M. Murphy, T. P. Flanigan, K. H. Mayer, and C. C. J. Carpenter. 1997. Detection of HIV-1 RNA in vaginal secretions of HIV-1 seropositive women who have undergone hysterectomy. AIDS 11:1296-1297.
8. Flore, J. R., A. Lepera, M. Di Stefano, A. Saracino, A. Favia, G. Pasture, and G. Angarano. 1999. Frequent cervicovaginal shedding of HIV-1 in asymptomatic, non-severely immunodeficient women. AIDS 13:626-627.
9. Gupta, P., J. Mellors, L. Kingsley, S. Riddler, M. K. Singh, S. Shreiber, M. Cronin, and C. R. Rinaldo. 1997. High viral load in semen of human immunodeficiency virus type 1-infected men at all stages of disease and its reduction by therapy with protease and nonnucleoside reverse transcriptase inhibitors. J. Virol. 71:6271-6275.
10. Hamed, K. A., M. A. Winters, M. Holodniy, D. A. Katzenstein, and T. C. Merigan. 1993. Detection of human immunodeficiency virus type 1 in semen: effects of disease stage and nucleoside therapy. J. Infect. Dis. 167:798-802.
11. Hart, C. E., J. L. Lennox, M. Pratt-Palmore, T. C. Wright, R. F. Schinazi, T. Evans-Strickfaden, T. J. Bush, C. Schnell, L. J. Conley, K. A. Clancy, and T. V. Ellerbrock. 1999. Correlation of human immunodeficiency virus type 1 RNA levels in blood and the female genital tract. J. Infect. Dis. 179:871-882.
12. Iverson, A. K. N., A. R. Larsen, T. Jensen, L. Fuggar, U. Balslev, S. Wahl, J. Gerstoft, J. I. Mullins, and P. Skinhøj. 1998. Distinct determinants of human immunodeficiency virus type 1 RNA and DNA loads in vaginal and cervical secretions. J. Infect. Dis. 177:1214-1220.
13. Lewis, P., R. Nduati, J. K. Kreiss, G. C. John, B. A. Richardson, D. Mbori-Ngacha, J. Ndinya-Achola, and J. Overbaugh. 1998. Cell-free human immunodeficiency virus type 1 in breast milk. J. Infect. Dis. 177:34-39.
14. Lin, H. J., L. E. Myers, B. Yen-Lieberman, F. B. Hollinger, D. Henrard, C. J. Hooper, R. Kokka, S. Kwok, S. Rasheed, M. Vahey, M. A. Winters, L. J. McQuay, P. L. Nara, P. Reicnelderfer, R. W. Coombs, and J. B. Jackson. 1994. Multicenler evaluation of methods for the quantitation of plasma HIV-1 RNA. J. Infect. Dis. 170:553-562.
15. Liuzzi, G., A. Chirianni, M. Clementi, P. Bagnarelli, A. Valenza, P. T. Cataldo, and M. Piazza. 1996. Analysis of HIV-1 viral load in blood, semen, and saliva: evidence for different viral compartments in a cross-sectional and longitudinal study. AIDS 10:F51-F56.
16. Rasheed, S., Z. Li, D. Xu, and A. Kovacs. 1996. Presence of cell-free human immunodeficiency virus in cervicovaginal secretions is independent of viral load in the blood of human immunodeficiency virus-infected women. Am. J. Obstet. Gynecol. 175:122-130.
17. Revets, H., D. Marissens, S. De Wit, P. Lacor, N. Clumeck, S. Lauwers, and G. Zissis. 1996. Comparative evaluation of NASBA HIV-1 RNA QT, Amplicor-HIV Monitor, and QUANTIPLEX HIV RNA assay, three methods for quantification of human immunodeficiency virus type 1 RNA in plasma. J. Clin. Microbiol. 34:1058-1064.
18. Rizzardini, G., D. Trabattoni, M. Saresella, S. Piconi, M. Lukwiya, S. Declich, M. Fabiani, P. Ferrante, and M. Clerici. 1998. Immune activation in HIV-infected African individuals. AIDS 12:2387-2396.
19. Rubertson, K., S. Fiscus, C. Kapoor, W. Robertson, G. Schneider, R. Shepard, L. Howe, S. Silva, and C. Hall. 1998. CSF, plasma viral load and HIV associated dementia. J. Neurovirol. 4:90-94.
20. Robinson, E. K., and B. G. Evans. 1999. Oral sex and HIV transmission. AIDS 13:737-738.
21. Royce, R. A., A. Sena, W. Cates, and M. S. Cohen. 1197. Sexual transmission of HIV. N. Engl. J. Med. 336:1072-1078.
22. Schuurman, R., D. Descamps, G. J. Weverling, S. Kaye, J. Tijnagel, I. Williams, R. van Leeuwen, R. Tedder, C. A. B. Boucher, F. Brun-Vezinet, and C. Loveday. 1996. Multicenter comparison of three commercial methods for quantification of human immunodeficiency virus type 1. RNA in plasma. J. Clin. Microbiol. 34:3016-3022.
23. Sei, S., S. K. Stewart, M. Farley, B. U. Mueller, J. R. Lane, M. L. Robb, P. Brouwer, and P. A. Pizzo. 1996. Evaluation of human immunodeficiency virus (HIV) type 1 RNA levels in cerebral spinal fluid and viral resistance to ZDV in children with HIV encephalopathy. J. Infect. Dis. 174:1200-1206.
24. Semba, R. D., N. Kumwenda, D. R. Hoover, T. E. Taha, T. C. Quinn, L. Mtimavalye, R. J. Biggar, R. Broadhead, P. G. Miotti, L. J. Sokoll, L. van der Hoeven, and J. D. Chiphangwi. 1999. Human immunodeficiency virus load in breast milk, mastitis, and mother-to-child transmission of human immunodeficiency virus type 1. J. Infect. Dis. 180:93-98.
25. Shugars, D. C., G. D. Slade, L. L. Patton, and S. A. Fiscus. Oral and systemic factors associated with increased levels of human immunodeficiency virus type 1 RNA in saliva. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., in press.
26. Spear, G. T., L. Al-Harthi, B. Sha, M. N. Saarloos, M. Hayden, L. S. Massad, C. Benson, K. A. Roebuck, N. R. Glick, and A. Landay. 1997 A potent activator of HIV-1 replication is present in the genital tract of a subset of HIV-1 infected and uninfected women. AIDS 11:1319-1326.
27. Staprans, S., N. Marlowe, D. Glidden, T. Novakovic-Agopian, R. M. Grant, M. Heyes, F. Aweeka, S. Deeks, and R. W. Price. 1999. Time course of cerebrospinal fluid responses to antiretroviral therapy: evidence for variable compartmentalization of infection. AIDS 13:1051-1061.
28. Tachet, A., E. Duliost, D. Salmon, M. De Almeida, S. Rivalland, L. Finkielsztejn, I. Heard, P. Jouannet, D. Sicard, and C. Rouzioux. 1999. Detection and quantification of HIV-1 in semen: identification of a subpopulation of men at high potential risk of viral sexual transmission. AIDS 13:823-831.
29. Vernazza, P. L., L. Troiani, M. J. Flepp, R. W. Cone, J. Schock, F. Roth, K. Boggian, M. S. Cohen, S. A. Fiscus, J. J. Eron, and The Swiss HIV Cohort Study. 2000. Potent antiretroviral treatment of HIV-infection results in suppression of the seminal shedding of HIV. AIDS 14:117-121.
30. Zhang, H., G. Dournadula, M. Beumont, L. Livornese, B. Van Uitert, K. Henning, and R. J. Pomerantz. 1998. Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy. N. Engl. J. Med. 339:1803-1809.